Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Innovex International (INVX) Research & Development (2016 - 2024)

Innovex International's Research & Development history spans 16 years, with the latest figure at $3.6 million for Q2 2024.

  • For Q2 2024, Research & Development rose 12.05% year-over-year to $3.6 million; the TTM value through Jun 2024 reached $13.4 million, up 11.96%, while the annual FY2023 figure was $12.6 million, 7.74% up from the prior year.
  • Research & Development reached $3.6 million in Q2 2024 per INVX's latest filing, down from $3.7 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $5.5 million in Q1 2020 to a low of $2.6 million in Q3 2022.
  • Average Research & Development over 5 years is $3.7 million, with a median of $3.6 million recorded in 2022.
  • Peak YoY movement for Research & Development: soared 52.75% in 2020, then tumbled 30.61% in 2021.
  • A 5-year view of Research & Development shows it stood at $4.0 million in 2020, then fell by 5.05% to $3.8 million in 2021, then fell by 29.6% to $2.7 million in 2022, then grew by 10.67% to $3.0 million in 2023, then grew by 20.12% to $3.6 million in 2024.
  • Per Business Quant, the three most recent readings for INVX's Research & Development are $3.6 million (Q2 2024), $3.7 million (Q1 2024), and $3.0 million (Q4 2023).